Farooq A Wandroo (@FWANDROO) profile picture

Hon.Assoc.Professor Univ of Birmingham,Head of Haematolgy, SWBH NHS Trust,interests in Myeloma/Lymph/leukemia,cricket, believes in duty of care@bkcf@bkma

Birmingham, England
Joined September 2010
Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)Photo by Farooq A Wandroo (@FWANDROO)
Farooq A Wandroo retweeted
Draft @NICEComms guidance for #pirtobrutinib Provisionally approved for R/R CLL Post cBTKI Ven Exposed or Naive Final guidance pending #CLL #pirtobrutinib
2
19
1,473
Farooq A Wandroo retweeted
NEW BMJ Research: Weight regain after cessation of medication for weight management bit.ly/4jy1ezY @_WestSam Linked Editorial exploring how weight management drugs are no magic bullets for treating obesity bit.ly/3LBnnkj
2
22
1
45
6,688
🔹 @BritSocHaem Guideline🔹 Investigation and management of thrombocytosis without JAK2, CALR or MPL mutations: A British Society for Haematology Guideline buff.ly/I0zHrBx
25
57
4,996
Farooq A Wandroo retweeted
#ASH25 Key abstract to watch in acute myeloid leukemia #AML #leusm 🧵 Overall Takeaways #Menin_inhibitors (revumenib, ziftomenib, enzomenib) are rapidly emerging as key agents in both frontline and R/R AML. Triplet regimens (VEN/AZA + targeted therapy) show promise across AML subtypes. Novel immunotherapies (bispecific FLT3×CD3) and CD123-directed therapy continue to expand the therapeutic landscape. Real-world data in TP53-mutant AML remain critical for optimizing HMA selection.
2
21
3
84
23,721
President @PEteiba has been visiting Members across the UK, this week in Birmingham. He spoke at the Midland Metropolitan University Hospital about how the College speaks up for the profession and the importance of working together. Thanks to our hosts and Members who attended.
6
2
9
1,920
Farooq A Wandroo retweeted
Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days nature.com/articles/s41408-0…
2
24
2
84
6,587
Farooq A Wandroo retweeted
The expansion of GLP-1 drug efficacy evidence in 2024, a concise review by @DanielJDrucker, a pioneer of the field nature.com/articles/s41574-0…
6
176
5
663
82,715
Farooq A Wandroo retweeted
Replying to @MorphologyAmigo
@MorphologyAmigo Dx – at Birmingham, England
1
1
183
‘We have been shocked at the awful racist and Islamophobic attacks that have taken place in UK cities over the past week.’ Dr @Mumtaz_Patel_1, acting RCP president, condemns the violent behaviour on the streets of UK cities: ow.ly/LfF950SRVNA
5
33
1
67
4,648
Farooq A Wandroo retweeted
Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management |American Journal of Hematology | Blood Research Journal | Wiley Online Library onlinelibrary.wiley.com/doi/… #mmsm
1
73
206
20,772
Chemo-free regimens (TKIs-blinatumomab) highly effective in Ph+ALL; may replace intensive chemoRx and allo SCT in most such patients in the future. Clinical Lymphoma, Myeloma and Leukemia doi.org/10.1016/j.clml.2024.… @NitinJainMD @NicholasShortMD @MDAndersonNews #leusm
1
19
2
91
5,095
Wishing good luck to all of the MRCP(UK) PACES candidates sitting their exams with our College this week! Our team is at Glasgow Royal Infirmary Tuesday to Friday and Sandwell General Hospital over the weekend. We'll be delivering exams across the UK this summer. #WeAreRCPSG
3
10
1,343
Farooq A Wandroo retweeted
Of 30 patients with severe #SickleCellDisease who were treated with gene-edited autologous hematopoietic stem and progenitor cells, 29 were free from vaso-occlusive crises for at least 12 consecutive months. Read the full CLIMB SCD-121 study results: nej.md/3UvzPDT
4
147
33
389
123,540
Farooq A Wandroo retweeted
A new study on the characterization of the B-cell receptor of monoclonal B lymphocytosis in siblings of patients with #chronicLymphocyticLeukemia ( #CLL ) provides insights into the early steps of the development of CLL. haematologica.org/article/vi…
2
18
40
3,790
Farooq A Wandroo retweeted
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers |American Journal of Hematology | Wiley Online Library onlinelibrary.wiley.com/doi/…
1
20
3
75
6,887
Ven Less is More: Ven 14 days non-inferior to 28 days in newly-diagnosed acute myeloid leukemia. onlinelibrary.wiley.com/doi/…
25
2
74
18,083
Farooq A Wandroo retweeted
Daratumumab and brentuximab vedotin combination therapy in T-cell acute lymphoblastic leukemia refractory to conventional chemotherapy and allogeneic stem cell transplant haematologica.org/article/vi…
13
20
2,165
Farooq A Wandroo retweeted
People in England with sickle cell disorder and thalassaemia will have NHS access to the world’s first blood group genotyping test, it has been announced. Read the latest #BSHNews story here: ow.ly/w2KU50QwcQu
2
6
918
Aza + ven + gilteritinib highly effective in newly dx older FLT3-mut #AML: CR/CRi 96% and 18-month OS 72%. A new standard of care in this population. @NicholasShortMD of @MDAndersonNews #Leukemia ascopubs.org/doi/10.1200/JCO… @JCO_ASCO #leusm
4
55
2
178
36,110